PainPathways lands on national shelves

A magazine focused on chronic, acute and cancer-related pain made the leap onto consumer newsstands in April, debuting at Barnes & Noble stores nationwide.

The quarterly magazine, PainPathways, has been distributed at clinics and primary care practices since last spring, and hopes to grab the attention of patients living with pain.  

The fifth issue features Montel Williams, a sufferer of multiple sclerosis, on the cover. Past issues have featured Dr. Oz, of The Oprah Winfrey Show, RealAge's Mike Roizen, and others. “We think it's an attractive piece, that patients will want to pick up,” said Shon Lawson Gilmore, senior managing editor. “It's not a pamphlet or a brochure.” 

The magazine hopes to eventually reach national drug stores and other consumer magazine retail spaces, including CVS, Walgreens, Target and Wal-Mart, said Gilmore. Additionally, PainPathways will continue to be delivered direct to doctors' offices. “Patients will see the magazine at the perfect time —just before visiting with their doctor,” noted Amy Taylor North, also a senior  managing editor at magazine. North added that the mag isn't targeted only to consumers. “We want to educate patients, caregivers and doctors,” she said.

According to Gilmore, several pharmas and biotechs are already advertising in the magazine, among them GlaxoSmithKline, King Pharmaceuticals, Boston Scientific and Elan. The back pages of PainPathways advertise clinical trials in the chronic, acute or cancer pain areas, and the magazine is currently looking into ways to incorporate advertising online, said Gilmore.

Richard Rauck, publisher and editor-in-chief of PainPathways, said he hopes the magazine will help to improve the lives of patients living with pain. “Patients can get information and inspiration [from the magazine],” said Rauk.  

Ad revenues fund the Sceptor Foundation, a non-profit founded by Rauk.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.